141 related articles for article (PubMed ID: 24455798)
1. Interpretation of hemolysis tests following administration of a second-generation hemoglobin-based oxygen carrier.
Drieghe S; Stove V; Decruyenaere J; Delanghe J
Acta Clin Belg; 2013; 68(4):282-6. PubMed ID: 24455798
[TBL] [Abstract][Full Text] [Related]
2. Impaired hemoglobin scavenging during an acute HIV-1 retroviral syndrome.
Delanghe JR; Philippé J; Moerman F; De Buyzere ML; Vynckier LL; Verstraete AG; Vogelaers DP; Vandekerckhove L
Clin Chim Acta; 2010 Apr; 411(7-8):521-3. PubMed ID: 20074563
[TBL] [Abstract][Full Text] [Related]
3. Pyridoxalated hemoglobin polyoxyethylene: a nitric oxide scavenger with antioxidant activity for the treatment of nitric oxide-induced shock.
Privalle C; Talarico T; Keng T; DeAngelo J
Free Radic Biol Med; 2000 May; 28(10):1507-17. PubMed ID: 10927175
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic studies of the oxidation of pyridoxalated hemoglobin polyoxyethylene conjugate by nitrogen monoxide.
Herold S
Arch Biochem Biophys; 1999 Dec; 372(2):393-8. PubMed ID: 10600181
[TBL] [Abstract][Full Text] [Related]
5. Relationship between chemical properties and biological properties of pyridoxalated hemoglobin-polyoxyethylene.
Iwashita Y
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):299-307. PubMed ID: 1391446
[TBL] [Abstract][Full Text] [Related]
6. Intravenous infusion of haptoglobin for the prevention of adverse clinical outcome in Sickle Cell Disease.
Quimby KR; Hambleton IR; Landis RC
Med Hypotheses; 2015 Oct; 85(4):424-32. PubMed ID: 26141635
[TBL] [Abstract][Full Text] [Related]
7. Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX).
Vincent JL; Privalle CT; Singer M; Lorente JA; Boehm E; Meier-Hellmann A; Darius H; Ferrer R; Sirvent JM; Marx G; DeAngelo J
Crit Care Med; 2015 Jan; 43(1):57-64. PubMed ID: 25083980
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobin and heme scavenger receptors.
Nielsen MJ; Møller HJ; Moestrup SK
Antioxid Redox Signal; 2010 Feb; 12(2):261-73. PubMed ID: 19659436
[TBL] [Abstract][Full Text] [Related]
9. Multicenter, randomized, placebo-controlled study of the nitric oxide scavenger pyridoxalated hemoglobin polyoxyethylene in distributive shock.
Kinasewitz GT; Privalle CT; Imm A; Steingrub JS; Malcynski JT; Balk RA; DeAngelo J
Crit Care Med; 2008 Jul; 36(7):1999-2007. PubMed ID: 18552688
[TBL] [Abstract][Full Text] [Related]
10. Modular Platform for the Development of Recombinant Hemoglobin Scavenger Biotherapeutics.
Buzzi RM; Owczarek CM; Akeret K; Tester A; Pereira N; Butcher R; Brügger-Verdon V; Hardy MP; Illi M; Wassmer A; Vallelian F; Humar R; Hugelshofer M; Buehler PW; Gentinetta T; Schaer DJ
Mol Pharm; 2021 Aug; 18(8):3158-3170. PubMed ID: 34292741
[TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation of a pyridoxylated-hemoglobin-polyoxyethylene conjugate.
Matsushita M; Yabuki A; Malchesky PS; Harasaki H; Nosé Y
Biomater Artif Cells Artif Organs; 1988; 16(1-3):247-60. PubMed ID: 3179467
[TBL] [Abstract][Full Text] [Related]
12. Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging.
Nielsen MJ; Moestrup SK
Blood; 2009 Jul; 114(4):764-71. PubMed ID: 19380867
[TBL] [Abstract][Full Text] [Related]
13. Conjugated human hemoglobin as a physiological oxygen carrier--pyridoxalated hemoglobin polyoxyethylene conjugate (PHP).
Malchesky PS; Takahashi T; Iwasaki K; Harasaki H; Nosé Y
Int J Artif Organs; 1990 Jul; 13(7):442-50. PubMed ID: 2205594
[TBL] [Abstract][Full Text] [Related]
14. CD163-expressing monocytes constitute an endotoxin-sensitive Hb clearance compartment within the vascular system.
Schaer CA; Vallelian F; Imhof A; Schoedon G; Schaer DJ
J Leukoc Biol; 2007 Jul; 82(1):106-10. PubMed ID: 17460152
[TBL] [Abstract][Full Text] [Related]
15. Autoxidation of pyridoxalated hemoglobin polyoxyethylene conjugate.
Talarico T; Swank A; Privalle C
Biochem Biophys Res Commun; 1998 Sep; 250(2):354-8. PubMed ID: 9753633
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of a pyridoxalated hemoglobin polyoxyethylene conjugate in reversing cell sickling.
Yabuki A; Matsushita M; Malchesky PS; Iwasaki K; Iwashita Y; Nosé Y
ASAIO Trans; 1988; 34(3):773-7. PubMed ID: 3196597
[TBL] [Abstract][Full Text] [Related]
17. Renal effects of multiple infusion of pyridoxalated-hemoglobin-polyoxyethylene conjugate (PHP) solution in dogs.
Takahashi T; Iwasaki K; Malchesky PS; Harasaki H; Matsushita M; Nosé Y; Rolin H; Hall PM
Artif Organs; 1993 Mar; 17(3):153-63. PubMed ID: 8215940
[TBL] [Abstract][Full Text] [Related]
18. Hemoglobin-based oxygen carriers: From mechanisms of toxicity and clearance to rational drug design.
Buehler PW; D'Agnillo F; Schaer DJ
Trends Mol Med; 2010 Oct; 16(10):447-57. PubMed ID: 20708968
[TBL] [Abstract][Full Text] [Related]
19. Enhanced splenomegaly and severe liver inflammation in haptoglobin/hemopexin double-null mice after acute hemolysis.
Tolosano E; Fagoonee S; Hirsch E; Berger FG; Baumann H; Silengo L; Altruda F
Blood; 2002 Dec; 100(12):4201-8. PubMed ID: 12393471
[TBL] [Abstract][Full Text] [Related]
20. Haptoglobin and CD163: captor and receptor gating hemoglobin to macrophage lysosomes.
Madsen M; Graversen JH; Moestrup SK
Redox Rep; 2001; 6(6):386-8. PubMed ID: 11865982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
